Morphological Assessment of Changes in the Macro- and Microvascular System of Lung Tissue in Diabetes Mellitus
DOI:
https://doi.org/10.62480/tjms.2023.vol19.pp9-12Keywords:
Diabetes mellitus, lung tissue, macrovascular system, microvascular systemAbstract
Diabetes mellitus is a chronic metabolic disease that affects various organs, including the lungs. The morphological changes of the macro- and microvascular systems of lung tissue in diabetes mellitus remain largely unknown, which affects our understanding of the pathogenesis of diabetic lung diseases. This article aims to review recent research on morphological assessments of changes in the macro- and microvascular system of lung tissue in diabetes mellitus, with a focus on the available techniques and their limitations, as well as their potential applications in preventing and treating diabetic lung diseases.
References
Matfin G, Jandhyala R. Respiratory complications of diabetes mellitus. Postgrad Med J. 2008 Nov;84(997):452-8.
Hundalani SG, Sheshadri S, Katz JN, et al. Diabetic lung disease: fact or fiction? Rev Endocr Metab Disord. 2020 Sep;21(3):331-40.
Rigato M, Smith AJ, Gambaro G, et al. Clinical aspects of diabetic nephropathy. J Diabetes. 2017 Feb;9(2):174-82.
Ghosh, S., Bhattacharya, A., & Dasgupta, A. (2018). The lung vasculature in diabetes. American Journal of Respiratory and Critical Care Medicine, 198(11), 1434-1435.
Kato, H., Ishida, J., Imagawa, S., Wachino, Y., & Fukushima, N. (2008). Pathological changes of small blood vessels under diabetic conditions. Pathology International, 58(5), 336-345.
Moraes TJ, Lefebvre DL, Chooniedass R, et al. The Canadian Healthy Infant Longitudinal Development (CHILD) Study: examining developmental origins of allergy and asthma. Thorax. 2015;70(10):998-1000.
Chaturvedi N, Sjolie AK, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet. 2003; 19-25;362(9393):2025-31.
Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16(2):434-44.
Lopes-Virella MF, Carter RE, Gilbert GE, et al. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care. 2008;31(10):2006-12.
Roldán-Molina R, García-Sánchez A, de la Rosa-Patrón A. Diabetes mellitus and lung cancer: a systematic review and meta-analysis. Endocr Connect. 2019;8(12):1665-74.
Torrisi SE, Ronchi A, Pistolesi M. Imaging of lung disease in patients with diabetes mellitus. Diabetes Res Clin Pract. 2018;144:280-9.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.